Filing Details

Accession Number:
0001209191-22-027232
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-04 19:01:26
Reporting Period:
2022-05-03
Accepted Time:
2022-05-04 19:01:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
818033 Heron Therapeutics Inc. HRTX Pharmaceutical Preparations (2834) 942875566
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202094 Kimberly Manhard 4242 Campus Point Court
Suite 200
San Diego CA 92121
Evp, Drug Development Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-29 1,504 $3.84 12,376 No 5 J Direct
Common Stock Disposition 2022-05-03 1,504 $4.76 10,872 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 J Direct
No 4 S Direct
Footnotes
  1. Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 29, 2022.
  2. The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 13, 2021.
  3. The range of sales prices received was $4.695 to $4.835. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.